Innophore

📍 Graz, Austria🗓 Founded 2017👥 24 employees💰 Last funded 2023
Biotechnology Research🌐 innophore.com
Website LinkedIn
Explore the platform for protein and drug discovery. Innophore is a cutting-edge drug and enzyme discovery platform that uses an artificial intelligence guided point-cloud technology to identify and optimize protein candidates for various use cases. We have leading global customers in the biotech and pharmaceutical industry, including Henkel, Continental, Merck and leading companies in the field of flavours and fragrances. Our AI-driven platform, fueled by massive computing power, not only analyzes a protein’s 3D structure, but includes extended surface properties (HALOS) and volumetric cavities (catalophores), to predict its characteristics and reactivity. This puts our customers at the forefront of tackling problems in drug discovery/repurposing and opens new ways in the sustainable production of high-value compounds. Accelerate your R&D pipeline. Over the course of 20 years, protein structure database entries have grown from 13,587 to nearly a billion. This includes a recently published breakthrough database from DeepMind and the ESM Metagenomic Atlas. It is easy to get lost in the vast amount of bioinformatics information available to us today. To identify new drug candidates or enzymes based on this vast amount of data, we need to change the way we search and go beyond traditional algorithms and data types. By integrating our patented CatalophoreTM technology with a state-of-the-art conventional bioinformatics approach, as well as artificial intelligence, we are able to mine structural and sequence databases using three-dimensional (3D) search templates called “catalophores” (i.e., carrier of the catalytic function) defined by point clouds of physicochemical features. The Inventors of Catalophores. Our CatalophoreTM platform improves your wet-lab performance by minimizing the volume of in-vitro screening experiments. Our in-silico approach significantly decreases time to market and increases the probability of your success.
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Austria
3
Investor activity2022–2023 · investors recorded per year
2022220231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Innophore?
Innophore has 3 investors on record on gritt.io and 3 late-stage investors.
When did Innophore last raise funding?
The most recent investment in Innophore recorded on gritt.io was in 2023.
When was Innophore founded?
Innophore was founded in 2017.
What industry is Innophore in?
Innophore operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Innophore based?
Innophore is headquartered in Graz, Austria.